Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_GrowTogether_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1837441699746140160.png) Learn & Grow Together [@_GrowTogether_](/creator/twitter/_GrowTogether_) on x XXX followers
Created: 2025-07-23 14:30:28 UTC

#SenoresPharma Q1 Update:

✅ CONS Net Profit: ₹197M vs ₹107M YoY
✅ Revenue: ₹1.38B vs ₹804M YoY
✅ EBITDA: ₹341M vs ₹213M YoY
✅ EBITDA Margin: XXXXX% vs XXXXX% YoY

#Pharma #Q1Results #StockMarket #Investing #Earnings #IndianMarkets


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948027939917889670/c:line.svg)

**Related Topics**
[investment](/topic/investment)
[stockmarket](/topic/stockmarket)

[Post Link](https://x.com/_GrowTogether_/status/1948027939917889670)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

GrowTogether Avatar Learn & Grow Together @GrowTogether on x XXX followers Created: 2025-07-23 14:30:28 UTC

#SenoresPharma Q1 Update:

✅ CONS Net Profit: ₹197M vs ₹107M YoY ✅ Revenue: ₹1.38B vs ₹804M YoY ✅ EBITDA: ₹341M vs ₹213M YoY ✅ EBITDA Margin: XXXXX% vs XXXXX% YoY

#Pharma #Q1Results #StockMarket #Investing #Earnings #IndianMarkets

XX engagements

Engagements Line Chart

Related Topics investment stockmarket

Post Link

post/tweet::1948027939917889670
/post/tweet::1948027939917889670